المؤلفون: Sandra Zazo, Sandra Pérez‐Buira, Nerea Carvajal, Jenifer Plaza‐Sánchez, Rebeca Manso, Nuria Pérez‐González, Carolina Dominguez, Iván Prieto‐Potin, Jaime Rubio, Manuel Dómine, Virginia Lozano, Patricia Mohedano, David Carcedo, Rafael Carias, Federico Rojo

المصدر: Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)

مصطلحات موضوعية: actionable mutation, lung cancer, molecular alterations, next‐generation sequencing, solid tumor, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/2045-7634

URL الوصول: https://doaj.org/article/f005a061fa8f46aca3f748bc4be3e83f

المؤلفون: Javier De Castro, Amelia Insa, Roberto Collado-Borrell, Vicente Escudero-Vilaplana, Alex Martínez, Elena Fernandez, Ivana Sullivan, Natalia Arrabal, David Carcedo, Alba Manzaneque

المصدر: BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-13 (2023)

مصطلحات موضوعية: Economic burden, Early-stage NSCLC, Locorregional relapse, Metastatic relapse, Diseases of the respiratory system, RC705-779

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2466

URL الوصول: https://doaj.org/article/6b5d735a63a64f3c8aa7226d4eca7c2b

المؤلفون: Dolores Isla, Marta Lopez-Brea, María Espinosa, Natalia Arrabal, Diego Pérez-Parente, David Carcedo, Reyes Bernabé-Caro

المصدر: Cost Effectiveness and Resource Allocation, Vol 21, Iss 1, Pp 1-11 (2023)

مصطلحات موضوعية: Atezolizumab, Cost-effectiveness analysis, IMpower110 trial, Non-small cell lung cancer, PD-L1 expression, Pembrolizumab, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1478-7547

URL الوصول: https://doaj.org/article/2223e9f6ac504c0f90862782b22ec2dc

المؤلفون: Federico Rojo, Esther Conde, Héctor Torres, Luis Cabezón-Gutiérrez, Dolores Bautista, Inmaculada Ramos, David Carcedo, Natalia Arrabal, J. Francisco García, Raquel Galán, Ernest Nadal

المصدر: BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)

مصطلحات موضوعية: C-ros oncogene 1, Non-small cell lung cancer, Molecular testing, Biomarker guided selection, Cost-effectiveness analysis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/b12bf91cf97542918d4058024d765d32

المؤلفون: Carlos Aguiar, Francisco Araujo, Gabriel Rubio-Mercade, David Carcedo, Silvia Paz, Jose María Castellano, Valentín Fuster

المصدر: Journal of Health Economics and Outcomes Research (2022)

مصطلحات موضوعية: Computer applications to medicine. Medical informatics, R858-859.7

وصف الملف: electronic resource

Relation: https://jheor.org/article/39768-cost-effectiveness-of-the-cnic-polypill-strategy-compared-with-separate-monocomponents-in-secondary-prevention-of-cardiovascular-and-cerebrovascular-d; https://doaj.org/toc/2327-2236

URL الوصول: https://doaj.org/article/347e85c17ece46d2a6bb79becbf9be51

المؤلفون: Ernest Nadal, Dolores Bautista, Luis Cabezón-Gutiérrez, Ana Laura Ortega, Héctor Torres, David Carcedo, Lucía Ruiz de Alda, J. Francisco Garcia, Paula Vieitez, Federico Rojo

المصدر: BMC Cancer, Vol 21, Iss 1, Pp 1-13 (2021)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1471-2407

URL الوصول: https://doaj.org/article/123ff71edeb9407a80aed7c523fce0ec

المؤلفون: Manuel García-Goñi, Isabel Río-Álvarez, David Carcedo, Alba Villacampa

المصدر: Pharmaceuticals, Vol 14, Iss 4, p 348 (2021)

مصطلحات موضوعية: biologics, biosimilars, budget impact analysis, savings, pharmaceutical spending, cost containment, Medicine, Pharmacy and materia medica, RS1-441

وصف الملف: electronic resource

Relation: https://www.mdpi.com/1424-8247/14/4/348; https://doaj.org/toc/1424-8247

URL الوصول: https://doaj.org/article/85631907015c4f7584b06507f7fe44c1

المؤلفون: Enrique de Alava, María Jesús Pareja, David Carcedo, Natalia Arrabal, José-Francisco García, Reyes Bernabé-Caro

المساهمون: Roche, Álava, Enrique de, Pareja, María Jesús, Carcedo, David, Bernabé Caro, Reyes

المصدر: Expert Review of Pharmacoeconomics & Outcomes Research. 22:1033-1042

مصطلحات موضوعية: Lung Neoplasms, molecular profiling, Cost-Benefit Analysis, Health Policy, High-Throughput Nucleotide Sequencing, Non-small cell lung cancer (NSCLC), General Medicine, Sequential single testing, oncogenic drivers, Hospitals, Oncogenic drivers, Molecular profiling, Carcinoma, Non-Small-Cell Lung, sequential single testing, Mutation, Next-generation sequencing, Humans, Cost-effectiveness, next-generation sequencing, Pharmacology (medical), cost-effectiveness

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8c7d0c203940c20777587b060d91a43
https://doi.org/10.1080/14737167.2022.2078310

المؤلفون: Edurne Arriola, Reyes Bernabé, Rosario García Campelo, Michele Biscuola, Ana Belén Enguita, Fernando López-Ríos, Rafael Martínez, Laura Mezquita, Sarai Palanca, María Jesús Pareja, Jon Zugazagoitia, Natalia Arrabal, J. Francisco García, David Carcedo, Enrique de Álava

المصدر: JCO Precision Oncology.

مصطلحات موضوعية: Cancer Research, Oncology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::b438be591a49314a7b138cc63ce4f6c2
https://doi.org/10.1200/po.22.00546

المؤلفون: Vicente Escudero-Vilaplana, Roberto Collado-Borrell, Javier De Castro, Amelia Insa, Alex Martínez, Elena Fernández, Ivana Sullivan, Andrés Flores, Natalia Arrabal, David Carcedo, Alba Manzaneque

المساهمون: Institut Català de la Salut, Escudero-Vilaplana V, Collado-Borrell R] Hospital Gregorio Marañon, Madrid, Spain. [De Castro J] Hospital Universitario La Paz, Madrid, Spain. [Insa A] Hospital Clínico Universitario de Valencia, Valencia, Spain. [Martínez A] Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Fernández E] OSI Bilbao-Basurto, Bilbao, Spain, Vall d'Hebron Barcelona Hospital Campus

المصدر: Scientia

مصطلحات موضوعية: Anticossos monoclonals - Ús terapèutic, Otros calificadores::/uso terapéutico [Otros calificadores], Health Policy, Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores], Neoplasms::Neoplasms by Site::Thoracic Neoplasms::Respiratory Tract Neoplasms::Lung Neoplasms::Bronchial Neoplasms::Carcinoma, Bronchogenic::Carcinoma, Non-Small-Cell Lung [DISEASES], neoplasias::neoplasias por localización::neoplasias torácicas::neoplasias del tracto respiratorio::neoplasias pulmonares::neoplasias de los bronquios::carcinoma broncogénico::carcinoma de pulmón de células no pequeñas [ENFERMEDADES], Other subheadings::Other subheadings::/drug therapy [Other subheadings], Health Policy, Planning and Management::Health Economics::Costs and Cost Analysis::Cost-Benefit Analysis [PUBLIC HEALTH], Políticas, Planificación y Administración en salud::economía de la salud::costes y análisis de costes::análisis coste-beneficio [SALUD PÚBLICA], Cost-eficàcia, Other subheadings::/therapeutic use [Other subheadings], Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal [CHEMICALS AND DRUGS], Pulmons - Càncer - Tractament, aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales [COMPUESTOS QUÍMICOS Y DROGAS]

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51dff73f7e9005c8f0c8725d8fed9d1a